Gold Pacific Co., Ltd. announced that it has received KRW 3.5 billion in funding
July 01, 2019
Share
Gold Pacific Co., Ltd. (KOSDAQ:A038530) announced a private placement of the 20th series unregistered unguaranteed private convertible bonds for proceeds of KRW 2,000,000,000, and 21st series unregistered unguaranteed private convertible bonds for proceeds of KRW 1,500,000,000, thereby raising aggregate proceeds of KRW 3,500,000,000 on July 1, 2019. The transaction included participation from individual investor Wanseop Han for the 20th and 21st series convertible bonds. The bonds are issued at 0% nominal interest rate, 0% yield to maturity, are fully convertible at a fixed conversion price of KRW 2,405 per share, are issued at par, and will mature on July 1, 2022. The conversion period for both the 20th and 21st series bonds is from July 1, 2020 to June 1, 2022. The 21st series convertible bonds are convertible into 623,700 common shares for 1.85% stake of the company, whereas the 20th series convertible bonds are convertible into 831,600 common shares for 2.45% stake of the company. The transaction was approved by board of directors of the company. The subscription and payment date of the transaction will be July 1, 2019.
KBio Company Inc, formerly Gold Pacific Co Ltd, is a Korea-based company primarily engaged in the bio distribution business. The Company operates its business through three segments. The Bio Distribution segment is engaged in the supply of research reagents and consumables to each customer through hospitals, universities, research institutes, and dealers. The Fashion segment is engaged in the production and sale of products such as handmade leather goods, clothing, and accessories. The Other segment is engaged in the fashion promotion business and other businesses.
KBIO COMPANY INC. 
